Benzinga | Sep 17, 2021 07:38AM EDT

Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)

https://www.globenewswire.com/news-release/2021/09/17/2299017/0/en/Novartis-announces-findings-from-a-real-world-study-of-alpelisib-demonstrating-clinical-benefit-in-people-with-PIK3CA-Related-Overgrowth-Spectrum-PROS.html